ARN Media (ASX:A1N) shareholders have endured a 58% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term ARN Media Limited (ASX:A1N) shareholders know that all too well, since the share price is down considerably over three years. Regrettably, they have had to cope with a 66% drop in the share price over that period. And over the last year the share price fell 35%, so we doubt many shareholders are delighted. Shareholders have had an even rougher run lately, with the share price down 16% in the last 90 days.
Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
ARN Media became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. So it's worth looking at other metrics to try to understand the share price move.
It's quite likely that the declining dividend has caused some investors to sell their shares, pushing the price lower in the process. In contrast it does not seem particularly likely that the revenue levels are a concern for investors.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
We know that ARN Media has improved its bottom line lately, but what does the future have in store? So we recommend checking out this free report showing consensus forecasts
It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for ARN Media the TSR over the last 3 years was -58%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!
ARN Media shareholders are down 32% for the year (even including dividends), but the market itself is up 11%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 8% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. It's always interesting to track share price performance over the longer term. But to understand ARN Media better, we need to consider many other factors. Case in point: We've spotted 2 warning signs for ARN Media you should be aware of.
Of course ARN Media may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
European Market Insights: genOway Société anonyme And 2 Promising Penny Stocks
The European market has shown resilience with the pan-European STOXX Europe 600 Index rising by 0.90%, buoyed by a slowdown in inflation and easing monetary policy from the European Central Bank. As investors navigate these evolving conditions, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential growth at accessible price points. Despite being an outdated term, penny stocks remain relevant as they can offer opportunities for those seeking to invest in financially strong companies with promising prospects. Name Share Price Market Cap Financial Health Rating Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ KebNi (OM:KEBNI B) SEK1.996 SEK541.22M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ Cellularline (BIT:CELL) €2.95 €62.22M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.78 €17.87M ★★★★★★ Abak (WSE:ABK) PLN4.00 PLN10.78M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.38 SEK2.28B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.62 SEK220.24M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.175 €300.29M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.936 €31.34M ★★★★★★ Click here to see the full list of 447 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: genOway Société anonyme is a biotechnology company that develops and commercializes custom genetically modified mouse, rat, and cell line models globally, with a market cap of €31.44 million. Operations: The company's revenue is derived entirely from its biotechnology segment, amounting to €27.53 million. Market Cap: €31.44M genOway Société anonyme, with a market cap of €31.44 million, has shown consistent revenue growth, reporting €22.06 million in sales for 2024, up from €20.05 million the previous year. The company maintains strong financial health with short-term assets exceeding both its short and long-term liabilities and a satisfactory net debt to equity ratio of 3.4%. Despite not outperforming the biotech industry in earnings growth last year, genOway's profitability has improved over five years at an impressive annual rate of 67.1%, supported by high-quality earnings and stable weekly volatility at 6%. Click here and access our complete financial health analysis report to understand the dynamics of genOway Société anonyme. Learn about genOway Société anonyme's historical performance here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kudelski SA, with a market cap of CHF67.34 million, offers digital access and security solutions for digital television and interactive applications across Switzerland, the United States, France, Germany, Austria, and other international markets. Operations: The company's revenue is primarily derived from three segments: Digital TV ($227.83 million), Cybersecurity ($108.47 million), and Internet of Things ($47.43 million). Market Cap: CHF67.34M Kudelski SA, with a market cap of CHF67.34 million, operates in digital access and security solutions across multiple markets. Despite being unprofitable with increasing losses over the past five years, it holds strong financials with short-term assets exceeding liabilities and more cash than debt. The seasoned management team and board bring stability, while recent partnerships in IoT and AI sectors highlight strategic growth efforts. Notably, Kudelski's collaboration with Stotz Equipment enhances asset visibility solutions without subscription fees, potentially driving future revenue streams within diverse industries like agriculture and construction. The stock trades significantly below estimated fair value compared to peers. Navigate through the intricacies of Kudelski with our comprehensive balance sheet health report here. Evaluate Kudelski's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: PCC Exol S.A. manufactures and distributes surfactants both in Poland and internationally, with a market cap of PLN452.76 million. Operations: The company's revenue is primarily derived from its Specialty Chemicals segment, totaling PLN996.33 million. Market Cap: PLN452.76M PCC Exol S.A., with a market cap of PLN452.76 million, shows promising financials as its short-term assets exceed both long-term and short-term liabilities. The company's earnings growth of 23.1% over the past year surpasses its five-year average and outpaces the broader Chemicals industry growth rate. However, while interest payments are well covered by EBIT, operating cash flow covers only 17% of debt, indicating potential liquidity concerns. Despite a high net debt to equity ratio of 54.1%, PCC Exol maintains high-quality earnings with no significant shareholder dilution recently and offers a price-to-earnings ratio below the Polish market average. Get an in-depth perspective on PCC Exol's performance by reading our balance sheet health report here. Explore historical data to track PCC Exol's performance over time in our past results report. Take a closer look at our European Penny Stocks list of 447 companies by clicking here. Interested In Other Possibilities? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:ALGEN SWX:KUD and WSE:PCX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Galantas Gold Enters Into Binding Term Sheet for Joint Venture With Ocean Partners UK Limited to Develop Omagh Gold Project in Northern Ireland
US$3.0 Million Investment for Exploration and Restart Plan, Shares for Debt Transactions and Notice of Annual General Meeting and Special Meeting TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) ('Galantas' or the 'Company') is pleased to announce that it has entered into a Binding Term Sheet with Ocean Partners UK Limited ('Ocean Partners') on June 6, 2025 to joint venture the high-grade Omagh Gold Project in County Tyrone, Northern Ireland (the 'Omagh Project'). Ocean Partners will exchange approximately US$14 million (GBP £10.3 million) in existing loans for an 80% interest in Flintridge Resources Limited ('Flintridge') and an 80% interest in Omagh Minerals Ltd ('Omagh Minerals'), subsidiaries of Galantas which together own the Omagh Project (the 'Proposed Transaction'). The remaining 20% interest in Flintridge and 20% interest in Omagh Minerals will be retained by Galantas. Following the Proposed Transaction, Ocean Partners will have the option to convert the approximately US$1 million (GBP £738,481) of remaining debt into a 0.001% interest in Flintridge at any time after mining has restarted on the Omagh Project. Ocean Partners will invest an initial US$3 million (GBP £2.2 million) in the Omagh Project for exploration, a restart plan and general and administrative costs for a period of up to one year (the 'Initial Term'). After the Initial Term, Ocean Partners will have the option to invest an additional US$5 million (GBP £3.7 million) for exploration and commissioning a development program for a period of up to one year (the 'Second Term'). Galantas will be free carried on the initial US$3 million (GBP £2.2 million) investment and will have the option to invest its pro-rata share on future investments, including the Second Term. Mario Stifano, CEO of Galantas, commented: 'We are very pleased to enter into the Proposed Transaction with Ocean Partners, a long-standing stakeholder who recognizes the district-scale and high-grade potential of the Omagh Project. The Proposed Transaction represents a turning point in the Omagh Project's development, enabling Galantas to benefit from a recommencement in production amid rising gold prices, while also strengthening the Company's balance sheet. The Company will have the benefit of receiving gold ounces once the Omagh Project is restarted, while also advancing the Gairloch high-grade gold and copper VMS project in Scotland. Upon closing of the Proposed Transaction, the joint venture intends to commence a drill program targeting the high-grade zones at the Omagh Project's Joshua Vein and test the northern extension of the Kearney Vein.' Rule 15 of the AIM Rules for Companies – Fundamental change of business The Proposed Transaction constitutes a fundamental change in business under Rule 15 of the AIM Rules for Companies by virtue of the size of the disposition and is subject to shareholder approval at a meeting or by a written shareholders' resolution signed by at least 50% of the shareholders of the issuer. Notwithstanding the Company proposes to divest substantially all of its trading business and assets, the Company will continue to be admitted to trading on AIM and will not be classified as an AIM Rule 15 cash shell. If the Proposed Transaction is concluded, Galantas will focus on initiating an inaugural mineral resource estimate at the Gairloch Project in Scotland and also commence an exploration drilling program at Gairloch. Upon closing of the Proposed Transaction, Ocean Partners and Galantas will sign a shareholders agreement (the 'Joint Venture') focused on exploration and restart plans with Ocean Partners as project operator. The board of directors of Flintridge shall be comprised of four representatives of Ocean Partners and one representative of the Company for so long as the Company owns at least a 10% interest in Flintridge. There will be no change to the board of directors of the Company following the Proposed Transaction. Flintridge will have a fixed valuation of US$15 million (GBP £11.1 million) for future cash calls. During the Initial Term, Galantas shall have the option (the 'Galantas Option') to convert its 20% ownership interest in Flintridge into a 3.00% net smelter return royalty (the '3% NSR'). 50% of the 3% NSR shall be subject to a buy-back provision for US$8 million (GBP £5.9 million) by Flintridge. In the event that: (i) Galantas does not exercise the Galantas Option during the Initial Term; and (ii) Galantas is diluted to below 10% ownership in Flintridge, the entirety of Galantas' ownership shall automatically convert to a 1.5% net smelter return royalty (the '1.5% NSR'). The remaining 50% of the 1.5% NSR shall be subject to a buy-back provision for US$4 million (GBP £3.0 million) by Flintridge. Galantas has entered into an exclusivity period with Ocean Partners regarding the Proposed Transaction, including without limitation, the settling of the form of Definitive Agreements, until the earlier of (i) the date of the execution of a mutually acceptable Definitive Agreements, (ii) the date upon which Ocean Partners and Galantas mutually agree in writing to terminate discussions, or (iii) June 30, 2025, unless extended by mutual agreement by Ocean Partners and Galantas. The Proposed Transaction remains subject to conditions precedent, including Ocean Partners board approval and completion of due diligence by Ocean Partners, the completion of definitive documentation and the receipt of all required approvals and consents, including shareholder approval by Galantas shareholders as well as formal filings with and approval from the TSX Venture Exchange. Ocean Partners is a person closely associated with Brent Omland, a Director of Galantas (within the meaning of the EU Market Abuse Regulation). Mr. Omland is Chief Executive Officer of Ocean Partners and is a nominee of Ocean Partners on the board of Galantas and holds a minority stake in, and is a director of, Ocean Partners' parent entity. AIM Rule 13 – Related-party transaction Melquart Limited ('Melquart'), a shareholder with 24.5% ownership, indicated that, subject to approval by the Company's shareholders, it intends to convert US$875,000 (GBP £646,171) of its debt held as a convertible note plus accrued interest of US$182,803 (GBP £134,997) into 17,630,050 common shares of no par value ('Common Shares') in Galantas at a deemed price of US$0.06 (GBP £0.044) per share (the 'Discounted Price') (the 'Melquart Debt Transaction'). Melquart is deemed a related party to the Company for the purposes of the AIM Rules for Companies. The Melquart Debt Transaction is considered a related-party transaction for the purposes of Rule 13 of the AIM Rules for Companies. Accordingly, the directors of the Company, who are all considered independent of the Melquart Debt Transaction, having consulted with their Nominated Adviser, consider that the terms of the Melquart Debt Transaction to be fair and reasonable in so far as the Company's shareholders ('Shareholders') are concerned. Following the Melquart Debt Transaction, Melquart will hold 47,372,977 Common Shares equal to approximately 35.4% of the Company's issued share capital. Multilateral Instrument 61-101 – Protection of Minority Security Holders The Company is exempt from the requirements of MI 61-101 to obtain a formal valuation and minority shareholder approval in connection with the Proposed Transaction with Ocean Partners in reliance on section 5.5(g) of MI 61-101. The Company is also exempt from the formal valuation requirements for the related party transaction with Melquart in reliance of section 5.5(g). Specifically, the Company in serious financial difficulty, the transaction is designed to improve the financial position of the Company, the Company is not in bankruptcy, insolvency or under a court order, the Company formed a committee comprised of three independent directors in respect of the transaction, and the Company's board of directors, acting in good faith, unanimously determined, including the independent committee, acting in good faith, determined that the Company is in serious financial difficulty and the transaction is designed to improve the financial position of the Company, and the terms of the transaction are reasonable in the circumstances of the Company. MI 61-101 does, however, require shareholder approval for the Melquart Debt Transaction by a majority of 'disinterested shareholders' as defined in MI 61-101. Additionally, pursuant to policies of the TSX Venture Exchange, the Proposed Transaction with Ocean Partners is being treated as a 'non-arm's length' transaction,and will also require shareholder approval by a majority of 'disinterested shareholders' as defined in MI 61-101. Notice of Annual General Meeting and Special Meeting The Company has called a new meeting date for its Annual General Meeting and Special Meeting of its Shareholders to consider, among other things, the Proposed Transaction and the Melquart Debt Transaction to be held on August 5, 2025 at 11:00 a.m. (Toronto time) at the offices of DSA Corporate Services Inc., 82 Richmond Street East, Toronto, Ontario, M5C 1P1. Shareholders of record at the close of business at 5:00 p.m. (Toronto time) on July 2, 2025 will be entitled to vote at the meeting. The total losses attributable to Flintridge and Omagh Minerals for the year ended December 31, 2023 were £3,516,576 and the total value of the assets were £17,321,724. Following the Proposed Transaction, the assets of Flintridge and Omagh Minerals will no longer be consolidated in the accounts of the Company. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain. About Galantas Gold Corporation Galantas Gold Corporation is a Canadian public company that trades on the TSX Venture Exchange and the London Stock Exchange AIM market, both under the symbol GAL. It also trades on the OTCQB Exchange under the symbol GALKF. The Company's strategy is to create shareholder value by operating and expanding gold production and resources at the Omagh Project in Northern Ireland, and exploring the Gairloch Project hosting the Kerry Road gold-bearing VMS deposit in Scotland. Enquiries Galantas Gold CorporationMario Stifano: Chief Executive OfficerEmail: info@ +44(0)28 8224 1100 Grant Thornton UK LLP (AIM Nomad)Philip Secrett, Harrison Clarke, Elliot PetersTelephone: +44(0)20 7383 5100 SP Angel Corporate Finance LLP (AIM Broker)David Hignell, Charlie Bouverat (Corporate Finance)Grant Barker (Sales & Broking) Telephone: +44(0)20 3470 0470 Forward-Looking Statements This news release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, including closing of the Proposed Transaction, Melquart Debt Transaction, and the Financing, and use of proceeds, results of exploration and mine development programs at the Omagh Project and Gairloch Project. Forward-looking statements are based on estimates and assumptions made by Galantas in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that Galantas believes are appropriate in the circumstances. Many factors could cause Galantas' actual results, the performance or achievements to differ materially from those expressed or implied by the forward looking statements or strategy, including: gold price volatility; discrepancies between actual and estimated production, actual and estimated metallurgical recoveries and throughputs; mining operational risk, geological uncertainties; regulatory restrictions, including environmental regulatory restrictions and liability; risks of sovereign involvement; speculative nature of gold exploration; dilution; competition; loss of or availability of key employees; additional funding requirements; uncertainties regarding planning and other permitting issues; and defective title to mineral claims or property. These factors and others that could affect Galantas' forward-looking statements are discussed in greater detail in the section entitled 'Risk Factors' in Galantas' Management Discussion & Analysis of the financial statements of Galantas and elsewhere in documents filed from time to time with the Canadian provincial securities regulators and other regulatory authorities. These factors should be considered carefully, and persons reviewing this news release should not place undue reliance on forward-looking statements. Galantas has no intention and undertakes no obligation to update or revise any forward-looking statements in this news release, except as required by law.
Bloomberg
an hour ago
- Bloomberg
Mekong Capital Plans a $200 Million Agriculture Fund Next Year
Mekong Capital Ltd., a Vietnam-focused private equity firm, plans to launch a regenerative agriculture fund in 2026 with as much as $200 in capital, according to its founder and partner Chris Freund. 'We're making progress getting that fund off the ground and currently at a stage where we're working on the pipeline' of potential companies to invest in, Freund said in an interview.
